Abiopharma

News list

Director Tammineedi Anil 🟡 adjusted position in 0 shares (1 derivative) of STEM, INC. (STEM) Transaction Date: Aug 07, 2026 | Filing ID: 000002

Full text

News bot Aug. 12, 2026, 1:22 a.m.
🔍 Tammineedi Anil (Director)

Company: STEM, INC. (STEM)

Report Date: 2026-08-07
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 7,486
- Total shares sold: 7,486
- Total shares held: 214,492
Detailed Transactions and Holdings:
- Acquired 7,486 shares of Common Stock, Par Value $0.0001 Per Share (Direct)
  Date: 2026-08-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,473.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock, Par Value $0.0001 Per Share (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: Held by Angeleno Investors III, L.P. | shares_owned_after: 214,492.00 | Footnotes: F2
- Sold 7,486 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-07 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3, F3
Footnotes:
- F1: Each restricted stock unit ("RSU") converted into a share of common stock on a one-for-one basis.
- F2: 214,492 shares held by Angeleno Investors III, L.P. Mr. Tammineedi is a Principal at Angeleno Group, an affiliate of Angeleno Investors III, L.P., and may be deemed to share voting and investment power with respect to all shares held by Angeleno Investors III, L.P.
- F3: On June 4, 2025, the reporting person was granted 7,486 RSUs vesting 100% on August 7, 2026.